Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats

Journal of Applied Physiology

Volumn 116, Issue 9, 2014, Pages 1156-1164

  Sheldon, Ryan D ^a,b   Laughlin, M Harold ^c,d   Rector, R Scott ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Akt; ENOS; Exercise; Hepatic; OLETF; Type 2 diabetes

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT;

ANIMAL; ANIMAL EXPERIMENT; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; ENZYMOLOGY; HYPERPHAGIA; LIVER; MALE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HYPERPHAGIA; LIVER; MALE; NITRIC OXIDE SYNTHASE TYPE III; NON-ALCOHOLIC FATTY LIVER DISEASE; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; RATS; RATS, INBRED OLETF;

EID: 84901236195     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01275.2013     Document Type: Article

References (48)

1. Bender SB, Newcomer SC, Laughlin MH. Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity. Am J Physiol Heart Circ Physiol 300: H1434-H1441, 2011.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395, 2004.
3. Bunker AK, Arce-Esquivel AA, Rector RS, Booth FW, Ibdah JA, Laughlin MH. Physical activity maintains aortic endothelium-dependent relaxation in the obese type 2 diabetic OLETF rat. Am J Physiol Heart Circ Physiol 298: H1889-H1901, 2010.
4. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. AMP-Activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
5. Chen Z, Bakhshi FR, Shajahan AN, Sharma T, Mao M, Trane A, Bernatchez P, van Nieuw Amerongen GP, Bonini MG, Skidgel RA, Malik AB, Minshall RD. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell 23: 1388-1398, 2012.
6. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13: 1579-1584, 2007.
7. Haram PM, Adams V, Kemi OJ, Brubakk AO, Hambrecht R, Elling-sen O, Wisloff U. Time-course of endothelial adaptation following acute and regular exercise. Eur J Cardiovasc Prev Rehabil 13: 585-591, 2006.
8. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278-1283, 1975.
9. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51: 2886-2894, 2002.
10. Johns DG, Dorrance AM, Tramontini NL, Webb RC. Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med (Maywood) 226: 27-31, 2001.
11. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28: 1982-1988, 2008.
12. Kroller-Schon S, Jansen T, Hauptmann F, Schuler A, Heeren T, Hausding M, Oelze M, Viollet B, Keaney JF Jr, Wenzel P, Daiber A, Munzel T, Schulz E. a1AMP-Activated protein kinase mediates vascular protective effects of exercise. Arterioscler Thromb Vasc Biol 32: 1632-1641, 2012.
13. Laughlin MH, Newcomer SC, Bender SB. Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell pheno-type. J Appl Physiol 104: 588-600, 2008.
14. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 249: G549-G556, 1985.
15. Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res 37: 891-903, 2007.
16. Lautt WW, Legare DJ, d'Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol Heart Circ Physiol 248: H331-H338, 1985.
17. Laye MJ, Rector RS, Borengasser SJ, Naples SP, Uptergrove GM, Ibdah JA, Booth FW, Thyfault JP. Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue. J Appl Physiol 106: 161-168, 2009.
18. Leifeld L, Fielenbach M, Dumoulin FL, Speidel N, Sauerbruch T, Spengler U. Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) expression in fulminant hepatic failure. J Hepatol 37: 613-619, 2002.
19. McNaughton L, Puttagunta L, Martinez-Cuesta MA, Kneteman N, Mayers I, Moqbel R, Hamid Q, Radomski MW. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U SA 99: 17161-17166, 2002.
20. Mei Y, Thevananther S. Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice. Hepatology 54: 1777-1789, 2011.
21. Mikus CR, Rector RS, Arce-Esquivel AA, Libla JL, Booth FW, Ibdah JA, Laughlin MH, Thyfault JP. Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats. J Appl Physiol 109: 1203-1210, 2010.
22. Mikus CR, Roseguini BT, Uptergrove GM, Morris EM, Rector RS, Libla JL, Oberlin DJ, Borengasser SJ, Taylor AM, Ibdah JA, Laughlin MH, Thyfault JP. Voluntary wheel running selectively augments insulin-stimulated vasodilation in arterioles from white skeletal muscle of insulin-resistant rats. Microcirculation 19: 729-738, 2012.
23. Mitchell BM, Dorrance AM, Mack EA, Webb RC. Glucocorticoids decrease GTP cyclohydrolase and tetrahydrobiopterin-dependent vasorelaxation through glucocorticoid receptors. J Cardiovasc Pharmacol 43: 8-13, 2004.
24. Mohan S, Reddick RL, Musi N, Horn DA, Yan B, Prihoda TJ, Natarajan M, Abboud-Werner SL. Diabetic eNOS knockout mice develop distinct macro-And microvascular complications. Lab Invest 88: 515-528, 2008.
25. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179. J Biol Chem 276: 30392-30398, 2001.
26. Morales-Ruiz M, Cejudo-Martin P, Fernandez-Varo G, Tugues S, Ros J, Angeli P, Rivera F, Arroyo V, Rodes J, Sessa WC, Jimenez W. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 125: 522-531, 2003.
27. Musso G, Gambino R, Cassader M, Pagano G. Meta-Analysis: natural history of non-Alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617-649, 2011.
28. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-Alcoholic fatty liver disease. J Hepatol 49: 608-612, 2008.
29. Pasarín M, Abraldes JG, Rodríguez-Vilarrupla A, La Mura V, García-Pagán JC, Bosch J. Insulin resistance and liver microcirculation in a rat model of early NAFLD. J Hepatol 55: 1095-1102, 2011.
30. Pasarín M, La Mura V, Gracia-Sancho J, García- Calderó H, Rodrí-guez-Vilarrupla A, García-Pagán JC, Bosch J, Abraldes JG. Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One 7: e32785, 2012.
31. Rector RS, Thyfault JP. Does physical inactivity cause nonalcoholic fatty liver disease? J Appl Physiol 111: 1828-1835, 2011.
32. Rector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, Ibdah JA. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294: G619-G626, 2008.
33. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-Alcoholic fatty liver disease in an obese rodent model. J Hepatol 52: 727-736, 2010.
34. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-Alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14: 185-192, 2008.
35. Rector RS, Uptergrove GM, Borengasser SJ, Mikus CR, Morris EM, Naples SP, Laye MJ, Laughlin MH, Booth FW, Ibdah JA, Thyfault JP. Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hy-perphagic OLETF rats. Am J Physiol Endocrinol Metab 298: E1179-E1187, 2010.
36. Rector RS, Uptergrove GM, Morris EM, Borengasser SJ, Laughlin MH, Booth FW, Thyfault JP, Ibdah JA. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300: G874-G883, 2011.
37. Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114: 344-351, 1998.
38. Rodriguez B, Torres DM, Harrison SA. Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol 9: 726-731, 2012.
39. Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol 280: G1209-G1216, 2001.
40. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100: 2923-2930, 1997.
41. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Choo K, Sessa WC, Groszmann RJ. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 117: 1222-1228, 1999.
42. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocor-ticoid-mediated effects on new and mature neurons. Nat Neurosci 11: 309-317, 2008.
43. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30: 1212-1218, 2007.
44. Tateya S, Rizzo NO, Handa P, Cheng AM, Morgan-Stevenson V, Daum G, Clowes AW, Morton GJ, Schwartz MW, Kim F. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes 60: 2792-2801, 2011.
45. Tsuchiya K, Accili D. Liver sinusoidal endothelial cells link hyperinsu-linemia to hepatic insulin resistance. Diabetes 62: 1478-1489, 2013.
46. 2+/calmodulin-dependent and tet-rahydrobiopterin regulatory process. J Biol Chem 273: 25804-25808, 1998.
47. Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA, Deleve LD. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 142: 918-927 e916, 2012.
48. Ying X, Jiang Y, Qian Y, Jiang Z, Song Z, Zhao C. Association between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in Chinese adults. Iran J Public Health 41: 45-49, 2012.